These findings are supported by previous studies conducted by Chen et al. (2021), which reported that SLNPs mitigate nephroinflammation in diabetic nephropathy rats by reducing both the protein level and gene expression of TNF-α and IL-6. Here, IL6 is linked to diabetic kidney disease.